Renal Cell Carcinoma Incidence Increasing Worldwide

Share this content:
Renal cell carcinoma incidence is on the rise in many countries, with widening mortality trends in less developed countries.
Renal cell carcinoma incidence is on the rise in many countries, with widening mortality trends in less developed countries.

Renal cell carcinoma (RCC) incidence is on the rise in many countries, with widening mortality trends in less developed countries, according to a study published in European Urology.

Researchers led by Ariana Znaor, MD, PhD, of the International Agency for Research on Cancer in France looked at data from GLOBOCAN, the Cancer Incidence in Five Continents series, and the World Health Organization mortality database to map out incidence rates in more than 40 countries.

They used joinpoint analyses of age-standardized rates (ASRs) in order to measure trends in the last ten years.

The study found that the incidence of RCC in men varied worldwide, with 1 in 100,000 in African countries to more than 15 in 100,000 in several European countries and among blacks in the U.S. 

RELATED: New Collaboration, Technology Changing Outlook for Some Metastatic Kidney Cancer Patients

They saw similar patterns in women, but the incidence rates were more likely half of those found in men.

Incidence rates are rising in many countries, most notably in Latin America, and while mortality trends are stabilizing, there is a significant decline in Western and Northern Europe, the U.S., and Australia.

“Although some progress towards stabilization of mortality trends has been achieved globally, differences in mortality between areas of higher and lower human development levels persist,” the authors concluded.

Reference

  1. Znaor, Ariana, et al. "International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality." European Urology. DOI: 10.1016/j.eururo.2014.10.002. March 1, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs